With our support, Prostate Cancer UK have been able to fund research that has helped to diagnose prostate cancer and develop the world’s first precision medicine for prostate cancer.
This long-standing collaboration has powered major breakthroughs in prostate cancer care:
- Revolutionising diagnosis: Funding research that replaced invasive biopsies with safer, more accurate MpMRI scans.
- Advancing treatment: Supporting the development of Olaparib – the world’s first precision medicine for prostate cancer, now available on the NHS.
- Responding to crisis: Launching the national ‘Find the 14,000’ campaign with NHS England to reach men who missed their diagnosis during the pandemic. The result? A surge in referrals and thousands of additional treatments.